SciCrunch will be offline today beginning at 6:30 PM PDT for about 15 minutes.
  • Register
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.


Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.


A role for AGL ubiquitination in the glycogen storage disorders of Lafora and Cori's disease.

Cori's disease is a glycogen storage disorder characterized by a deficiency in the glycogen debranching enzyme, amylo-1,6-glucosidase,4-alpha-glucanotransferase (AGL). Here, we demonstrate that the G1448R genetic variant of AGL is unable to bind to glycogen and displays decreased stability that is rescued by proteasomal inhibition. AGL G1448R is more highly ubiquitinated than its wild-type counterpart and forms aggresomes upon proteasome impairment. Furthermore, the E3 ubiquitin ligase Malin interacts with and promotes the ubiquitination of AGL. Malin is known to be mutated in Lafora disease, an autosomal recessive disorder clinically characterized by the accumulation of polyglucosan bodies resembling poorly branched glycogen. Transfection studies in HepG2 cells demonstrate that AGL is cytoplasmic whereas Malin is predominately nuclear. However, after depletion of glycogen stores for 4 h, approximately 90% of transfected cells exhibit partial nuclear staining for AGL. Furthermore, stimulation of cells with agents that elevate cAMP increases Malin levels and Malin/AGL complex formation. Refeeding mice for 2 h after an overnight fast causes a reduction in hepatic AGL levels by 48%. Taken together, these results indicate that binding to glycogen crucially regulates the stability of AGL and, further, that its ubiquitination may play an important role in the pathophysiology of both Lafora and Cori's disease.

Pubmed ID: 17908927


  • Cheng A
  • Zhang M
  • Gentry MS
  • Worby CA
  • Dixon JE
  • Saltiel AR


Genes & development

Publication Data

October 1, 2007

Associated Grants

  • Agency: NIDDK NIH HHS, Id: 2R01DK060597-06
  • Agency: NINDS NIH HHS, Id: K99 NS061803
  • Agency: NINDS NIH HHS, Id: R00 NS061803
  • Agency: NINDS NIH HHS, Id: R00 NS061803-03

Mesh Terms

  • Animals
  • Binding Sites
  • Carrier Proteins
  • Cell Line
  • Glucans
  • Glycogen
  • Glycogen Debranching Enzyme System
  • Glycogen Storage Disease
  • Glycogen Storage Disease Type III
  • Humans
  • Lafora Disease
  • Mice
  • Ubiquitin